TF
Serotransferrin
Also known as: PRO1557, PRO2086, TRFE_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P02787
- Gene
- TF
- Ensembl
- ENSG00000091513
- Chromosome
- 3
- Canonical length
- 698 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a glycoprotein with an approximate molecular weight of 76.5 kDa. It is thought to have been created as a result of an ancient gene duplication event that led to generation of homologous C and N-terminal domains each of which binds one ion of ferric iron. The function of this protein is to transport iron from the intestine, reticuloendothelial system, and liver parenchymal cells to all proliferating cells in the body. This protein may also have a physiologic role as granulocyte/pollen-binding protein (GPBP) involved in the removal of certain organic matter and allergens from serum. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
698 residues, UniProt reviewed canonical sequence.
>P02787|TF
1 MRLAVGALLV CAVLGLCLAV PDKTVRWCAV SEHEATKCQS FRDHMKSVIP SDGPSVACVK
61 KASYLDCIRA IAANEADAVT LDAGLVYDAY LAPNNLKPVV AEFYGSKEDP QTFYYAVAVV
121 KKDSGFQMNQ LRGKKSCHTG LGRSAGWNIP IGLLYCDLPE PRKPLEKAVA NFFSGSCAPC
181 ADGTDFPQLC QLCPGCGCST LNQYFGYSGA FKCLKDGAGD VAFVKHSTIF ENLANKADRD
241 QYELLCLDNT RKPVDEYKDC HLAQVPSHTV VARSMGGKED LIWELLNQAQ EHFGKDKSKE
301 FQLFSSPHGK DLLFKDSAHG FLKVPPRMDA KMYLGYEYVT AIRNLREGTC PEAPTDECKP
361 VKWCALSHHE RLKCDEWSVN SVGKIECVSA ETTEDCIAKI MNGEADAMSL DGGFVYIAGK
421 CGLVPVLAEN YNKSDNCEDT PEAGYFAIAV VKKSASDLTW DNLKGKKSCH TAVGRTAGWN
481 IPMGLLYNKI NHCRFDEFFS EGCAPGSKKD SSLCKLCMGS GLNLCEPNNK EGYYGYTGAF
541 RCLVEKGDVA FVKHQTVPQN TGGKNPDPWA KNLNEKDYEL LCLDGTRKPV EEYANCHLAR
601 APNHAVVTRK DKEACVHKIL RQQQHLFGSN VTDCSGNFCL FRSETKDLLF RDDTVCLAKL
661 HDRNTYEKYL GEEYVKAVGN LRKCSTSSLL EACTFRRPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 7,020 nTPM
Expression across tissuesHPA
Tissue
- liver: 7,020 nTPM
- retina: 2,257 nTPM
- spinal cord: 887 nTPM
- midbrain: 263 nTPM
- hippocampal formation: 193 nTPM
- cerebral cortex: 176 nTPM
Single-cell type
- müller glia: 11,977 nCPM
- hepatocytes: 8,185 nCPM
- oligodendrocytes: 1,269 nCPM
- lacrimal acinar cells: 154 nCPM
- submucosal glandular cells: 125 nCPM
- salivary basal cells: 112 nCPM
Immune cell
- basophil: 0.6 nTPM
- neutrophil: 0.4 nTPM
- classical monocyte: 0.1 nTPM
- eosinophil: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- intermediate monocyte: 0.1 nTPM
Brain region
- white matter: 1,681 nTPM
- medulla oblongata: 1,580 nTPM
- cerebellum: 1,169 nTPM
- pons: 1,082 nTPM
- spinal cord: 940 nTPM
- basal ganglia: 770 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TF.
Disease | AllUniProt
Conditions TF is implicated in, by any mechanism.
- Atransferrinemia (ATRAF) MIM:209300
Disease | GeneticClinVar
17 pathogenic / likely-pathogenic of 504 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Atransferrinemia
- Transferrin variant D1
- Transferrin variant Bv
Disease | ImmuneIEDB
Conditions an epitope on TF was assayed in.
- rheumatoid arthritis B cell
- brain glioma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.46
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antibacterial humoral response
- cell surface receptor signaling pathway
- cellular response to iron ion
- intracellular iron ion homeostasis
- iron ion transport
- multicellular organismal-level iron ion homeostasis
- osteoclast differentiation
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- positive regulation of receptor-mediated endocytosis
- regulation of protein stability
Molecular functions
- enzyme binding
- ferric iron binding
- ferrous iron binding
- iron chaperone activity
- transferrin receptor binding
- transmembrane transporter binding
Cellular components
- apical plasma membrane
- basal part of cell
- basal plasma membrane
- blood microparticle
- cell surface
- clathrin-coated endocytic vesicle membrane
- clathrin-coated pit
- cytoplasmic vesicle
- early endosome
- endocytic vesicle
- endoplasmic reticulum lumen
- endosome membrane
- extracellular exosome
- extracellular region
- extracellular space
- HFE-transferrin receptor complex
- late endosome
- perinuclear region of cytoplasm
- plasma membrane
- recycling endosome
- secretory granule lumen
- vesicle
Protein domainsUniProt · Pfam · InterPro
- Transferrin-like domain
- Transferrin
- Transferrin family, iron binding site
- Transferrin
- Serotransferrin, mammalian
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TF in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TF as an antibody target. Whether an autoantibody or antibody against TF could matter depends on whether native TF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TF is annotated as secreted, so native TF circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label TF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...